8-K: USANA Health Sciences Reports Q1 2026 Results

USANA Health Sciences announced its first quarter 2026 financial results, showing flat net sales and a decrease in net earnings, while reiterating its full-year guidance.

Summary

• USANA Health Sciences reported first quarter 2026 net sales of $250 million, flat compared to the prior year, with a 3% positive impact from currency exchange rates.
• Net earnings for the quarter were $7.5 million, a decrease of 20% year-over-year, resulting in diluted EPS of $0.41, down from $0.49.
• Adjusted diluted EPS was $0.61, down 16% from $0.73 in the prior year.
• Adjusted EBITDA was $28.4 million, a 5% decrease from $29.8 million in the first quarter of 2025.
• Core Nutritional active customers decreased by 12% to 404,000, and Hiya active monthly subscribers decreased by 17% to 186,000.
• The company reiterated its fiscal year 2026 guidance for consolidated net sales between $925 million and $1.0 billion.
• The company ended the quarter with $163 million in cash and cash equivalents and $14 million in debt.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly cautious sentiment, reflecting a mix of sequential improvements and strategic investments offset by year-over-year declines in key metrics and ongoing challenges in certain business segments.

Positives

• Net sales remained flat year-over-year at $250 million, with a positive 3% currency impact.
• Core Nutritional business showed sequential improvement with net sales up 7% and active customers up 4% from the previous quarter.
• Hiya Health experienced modest sequential improvement in net sales (+7%) and active monthly subscribers (+2%).
• Rise Wellness demonstrated significant year-over-year growth (+741%) and sequential growth (+143%) in net sales.
• The company maintains a strong balance sheet with $163 million in cash and cash equivalents.
• Inventory levels decreased by 7% to $99 million, driven by strong performance in Rise Wellness orders.

Negatives

• Net earnings decreased by 20% year-over-year to $7.5 million.
• Diluted EPS fell 16% to $0.41 compared to $0.49 in the prior year.
• Adjusted diluted EPS decreased by 16% to $0.61.
• Adjusted EBITDA declined 5% year-over-year to $28.4 million.
• Core Nutritional active customers decreased by 12% year-over-year to 404,000.
• Hiya active monthly subscribers decreased by 17% year-over-year to 186,000.
• Gross margin decreased by 280 basis points year-over-year to 76.2%, largely due to lower margins in Rise Wellness.
• The effective tax rate increased to 55.0% in Q1 2026 from 44.5% in Q1 2025.

Risks

• Risks related to global economic conditions, including inflationary pressures impacting operating costs and consumer demand.
• Reliance on the network of independent Brand Partners and potential issues with the compensation plan.
• Risks associated with launching new or reformulated products.
• Challenges for Hiya in adapting to digital marketing changes and social media advertising algorithms.
• Dependence of Rise Wellness on orders from key retailers and the risk of discontinuation of purchases.
• Governmental regulation of products, manufacturing, and direct selling business models.
• Potential negative effects from deteriorating foreign relations, trade policies, tariffs, and geopolitical conflicts.
• Compliance with data privacy and security laws, and risks of material breaches of IT systems.

Future Outlook

The company reiterates its fiscal year 2026 guidance, projecting consolidated net sales between $925 million and $1.0 billion, net earnings of $20 million to $27 million, and adjusted diluted EPS between $1.95 and $2.29. The company expects Hiya net sales to be between $140 million and $155 million, and Rise Wellness net sales between $65 million and $80 million.

Management Comments

• "Our first quarter 2026 results reflect USANAs continued evolution from a single-channel direct sales business to a diversified, omnichannel health and wellness enterprise."
• "Our omnichannel platform is intended to provide multiple growth engines, and early progress across our three segments reinforces confidence that our strategy will deliver sustained incremental value over time."
• "The Core Nutritional business delivered solid sequential improvement during the quarter, driven by growth in total active customers in China in addition to continued focus on accelerating our new product launch initiatives."
• "Hiya established the operational foundation for a meaningfully stronger second half of the year and Rise Wellness generated triple-digit growth as Protein Pop hit Costco shelves nationwide."
• "As we look ahead, the investments we are making today in product innovation, brand building, channel expansion, and technology modernization reinforce confidence in our strategic direction."
• "We are reaffirming our fiscal 2026 guidance across all metrics. Our first quarter results, while reflecting continued year-over-year pressure in portions of our business, saw meaningful sequential improvement and provide us with confidence that the foundational investments we are making and the strategic actions underway are beginning to produce measurable results."

Industry Context

StockSavvy.ai notes that USANA's strategic shift towards an omnichannel model reflects a broader industry trend of direct-to-consumer (DTC) brands diversifying their sales channels to include retail and other platforms to broaden consumer reach and mitigate reliance on single channels.

Comparison to Industry Standards

• The decline in Core Nutritional active customers (12% YoY) and Hiya subscribers (17% YoY) contrasts with the growth seen by some competitors in the broader health and wellness sector who are leveraging digital marketing more effectively.
• Rise Wellness's significant year-over-year growth (+741%) is a positive outlier, driven by strategic retail partnerships like Costco, a strategy that has proven successful for other CPG brands entering the mass retail space.
• The company's focus on technology modernization and leveraging third-party platforms aligns with industry best practices for enhancing customer engagement and operational efficiency.

Stakeholder Impact

• Shareholders: The flat net sales and decreased net earnings may temper short-term investor enthusiasm, but the reiteration of full-year guidance and strategic investments aim for long-term value creation.
• Brand Partners: The enhanced Brand Partner compensation plan is intended to strengthen the business opportunity and improve productivity and retention.
• Customers: The company is investing in technology modernization to improve customer engagement and brand experience.
• Suppliers: The shift to in-house manufacturing for Hiya products may impact existing suppliers but aims to improve margins and control for USANA.

Next Steps

• Continue executing the three strategic priorities for the Core Nutritional business: reinvigorating the sales force, accelerating product innovation, and modernizing technology infrastructure.
• Focus on re-accelerating subscriber acquisition for Hiya Health.
• Continue to invest in Rise Wellness for long-term growth, aiming for margin improvement as brands mature and volumes scale.
• Implement in-house manufacturing for Hiya products to achieve operational efficiencies in the second half of 2026.
• Expand Hiya's international presence with launches in Canada and the UK, and further develop retail distribution.
• Continue technology modernization initiative, leveraging third-party platforms for efficiency and scalability.

Key Dates

Recommendation

The company is in a transitional phase, shifting to an omnichannel model. While there are positive sequential improvements and strong growth in new segments like Rise Wellness, the year-over-year declines in core metrics and customer numbers warrant caution. The reiteration of guidance suggests stability, but significant catalysts for substantial upside are not yet fully realized. A 'hold' recommendation reflects the balance between ongoing strategic execution and current performance trends.

Keywords

USANA Health Sciences, Q1 2026 Earnings, Nutritional Supplements, Omnichannel Health, Direct Selling, Hiya Health, Rise Wellness, Financial Results